companydata.dkcompanydata.dk

MEDIPART ApS: Financial statements 2025

CVR: 28895399

Source: annual report 2025, Danish Business Authority

01/08/2024 – 31/07/2025

MEDIPART ApS (CVR 28895399) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -64,509 and a net result of DKK 138,106 compared with DKK 4,660 the year before. Equity in the 2025 report amounted to DKK 11,652,834. The solvency ratio was 99.5%. The company had 1 employee in the financial year.

Gross Profit
DKK -64,509
Profit/Loss
DKK 138,106
Equity
DKK 11,652,834
Total Assets
DKK 11,708,781
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025--65 t.138 t.11.7 mio.1
2024--326 t.5 t.11.5 mio.1
2023--706 t.-1.5 mio.11.5 mio.1
2022--155 t.862 t.13 mio.1
2021-7.6 mio.5.6 mio.12.2 mio.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is MEDIPART ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

MEDIPART ApS: The 2024 annual report is outJan 22, 2025

MEDIPART ApS has published its annual report for 2024. Gross profit came to DKK -325,864, and the net result was DKK 4,660.

Auditor steps down at MEDIPART ApSJan 22, 2025

As of January 22, 2025, A/S PSE 17 NR. 1056 has stepped down as auditor of MEDIPART ApS.

About MEDIPART ApS

MEDIPART ApS is a Danish company of the type Anpartsselskab based in Middelfart, founded in 2005. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Rikke Nygaard. The company is owned by Erik Nygaard. The company has 1 employee (2024). In 2025, the company reported a gross profit of DKK -64,509 and a net result of DKK 138,106 compared with DKK 4,660 the year before. Equity in the 2025 report amounted to DKK 11,652,834.

Source: annual report 2025, Danish Business Authority